La Stamp, an Italian daily newspaper, revealed that the European Union (EU) may not extend its contracts with either AstraZeneca or Johnson& Johnson companies that produce anti-Corona (known also as COVID-19) vaccines next year.
The newspaper assured that Italy's Prime Minister Mario Draghi and other heads of European governments will decide not extending contracts the companies that develop vaccines based on the technique of the Viral vector.
The Italian newspaper implied that the European restrictions may also include Sputnik V, the Russian-made, which is not licensed by the European Drugs Agency, Reithera an Italian vaccine.
As of the next year, Italy and other European countries will use only vaccine produces by Pfizer and Moderna companies only as the two vaccines adopted techniques of RNA.
According to La Stampa, there is a second option to extend contractions with AstraZeneca and Johnson& Johnson the next year but to reduce the quantity of doses and use these vaccines with people above 60 years.
The senior people do not susceptible to colligation after receiving these sorts of vaccines.
It is worth noting that a number of European countries decided to suspend the anti-Corona vaccine made AstraZeneca after reports of cases of colligation.
In the same context, Denmark announced relinquishing AstraZeneca vaccine at all.
The vaccine produced by Johnson & Johnson Company stirs the same fears like of AstraZeneca, a British drug giant.
The British company announced that it respects the decision of the Danish health authorities due a very rare type of thrombosis in some people who received its vaccine.
The company issues a statement says that it convinces and respects the decision made by the Health Agency in Denmark as every country has the right to decide its programs of vaccination according to local circumstances.
Denmark becomes the first country that withdraws the AstraZeneca vaccine from the national program for vaccination against the pandemic.
Follow the latest news on Google News
